AARTI PHARMALABS
Back to Balance Sheet
|
AARTI PHARMALABS Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹3,482 Cr | ₹2,902 Cr | ₹2,582 Cr | ₹2,244 Cr | ₹2,040 Cr |
What is the latest Total Liabilities ratio of AARTI PHARMALABS ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹3,482 Cr |
| Mar2025 | ₹2,902 Cr |
| Mar2024 | ₹2,582 Cr |
| Mar2023 | ₹2,244 Cr |
| Mar2022 | ₹2,040 Cr |
How is Total Liabilities of AARTI PHARMALABS Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,482 Cr | 19.96 | |
| Mar2025 | ₹2,902 Cr | 12.41 | |
| Mar2024 | ₹2,582 Cr | 15.07 | |
| Mar2023 | ₹2,244 Cr | 10.01 | |
| Mar2022 | ₹2,040 Cr | - | |
Compare Total Liabilities of peers of AARTI PHARMALABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AARTI PHARMALABS | ₹7,937.6 Cr | -0.3% | 7.7% | 3.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹422,283.0 Cr | 0.1% | -5% | 5.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹244,762.0 Cr | -1.7% | 0.2% | 39.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,448.0 Cr | -2.5% | -5.5% | 30.2% | Stock Analytics | |
| CIPLA | ₹107,043.0 Cr | 0.9% | -2.6% | -14.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,820.0 Cr | 0.1% | 7.6% | -3.5% | Stock Analytics | |
AARTI PHARMALABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AARTI PHARMALABS | -0.3% |
7.7% |
3.7% |
| SENSEX | 3.1% |
1% |
-9.1% |
You may also like the below Video Courses